nitroglycerin has been researched along with Glycogen Storage Disease Type I in 1 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, PJ | 1 |
| Celermajer, DS | 1 |
| Robinson, J | 1 |
| McCarthy, SN | 1 |
| Betteridge, DJ | 1 |
| Leonard, JV | 1 |
1 other study available for nitroglycerin and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a.
Topics: Adult; Arteriosclerosis; Endothelium, Vascular; Female; Glycogen Storage Disease Type I; Humans; Hyp | 1994 |